Persons with dispensed medicines; age and sex

Edit table Show description

Persons with dispensed medicines; age and sex
Sex Ages Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female Total age A02 Drugs for acid related disorders 2022* 12.48
Total male and female Total age A02B Drugs for peptic ulcer and gord 2022* 12.48
Total male and female Total age A02X Oth. drugs for acid related disord. 2022* 0.00
Total male and female Total age A03 Drugs for funct.gastrointest.disord. 2022* 2.08
Total male and female Total age A03A Drugs for functional bowel disord. 2022* 0.50
Total male and female Total age A14 Anabolic agents for systemic use 2022* 0.00
Total male and female Total age B Blood and blood forming organs 2022* 13.22
Total male and female Total age D01 Antifungals for dermatological use 2022* 4.48
Total male and female Total age D01A Antifungals for topical use 2022* 4.11
Total male and female Total age D01B Antifungals for systemic use 2022* 0.47
Total male and female Total age D03 Means for wounds & ulcers treatment 2022* 0.01
Total male and female Total age D05A Antipsoriatics for topical use 2022* 0.49
Total male and female Total age D05B Antipsoriatics for systemic use 2022* 0.02
Total male and female Total age D06 Antibiotics.. for dermatological use 2022* 4.12
Total male and female Total age D06A Antibiotics for topical use 2022* 3.45
Total male and female Total age D06B Chemotherapeutics for topical use 2022* 0.73
Total male and female Total age G02B Contraceptives for topical use 2022* 0.09
Total male and female Total age H02 Corticosteroids for systemic use 2022* 4.71
Total male and female Total age J General antiinfectives for system.use 2022* 19.33
Total male and female Total age J01 Antibacterials for systemic use 2022* 17.87
Total male and female Total age J02 Antimycotics for systemic use 2022* 0.87
Total male and female Total age J02A Antimycotics for systemic use 2022* 0.87
Total male and female Total age J04A Drugs for treatment of tuberculosis 2022* 0.04
Total male and female Total age J04B Drugs for treatment of lepra 2022* 0.01
Total male and female Total age J05 Antivirals for systemic use 2022* 0.66
Total male and female Total age M05 Drugs for treatment of bone diseases 2022* 1.23
Total male and female Total age M09 Oth.drugs for musculo-skelet.disord. 2022* 0.00
Total male and female Total age R03 Drugs for obstruct. airway diseases 2022* 8.38
Total male and female Total age R03C Adrenergics for systemic use 2022* 0.00
Total male and female Total age R06 Antihistamines for systemic use 2022* 7.27
Total male and female Total age R06A Antihistamines for systemic use 2022* 7.27
Total male and female Total age V06A Obesity treatment diet formulations 2022* 0.00
Total male and female Total age V06C Infant formulas 2022* 0.00
Total male and female 0 to 15 years A02 Drugs for acid related disorders 2022* 0.50
Total male and female 0 to 15 years A02B Drugs for peptic ulcer and gord 2022* 0.50
Total male and female 0 to 15 years A02X Oth. drugs for acid related disord. 2022* 0.00
Total male and female 0 to 15 years A03 Drugs for funct.gastrointest.disord. 2022* 0.32
Total male and female 0 to 15 years A03A Drugs for functional bowel disord. 2022* 0.03
Total male and female 0 to 15 years A14 Anabolic agents for systemic use 2022* 0.00
Total male and female 0 to 15 years B Blood and blood forming organs 2022* 0.68
Total male and female 0 to 15 years D01 Antifungals for dermatological use 2022* 2.86
Total male and female 0 to 15 years D01A Antifungals for topical use 2022* 2.80
Total male and female 0 to 15 years D01B Antifungals for systemic use 2022* 0.08
Total male and female 0 to 15 years D03 Means for wounds & ulcers treatment 2022* 0.00
Total male and female 0 to 15 years D05A Antipsoriatics for topical use 2022* 0.08
Total male and female 0 to 15 years D05B Antipsoriatics for systemic use 2022* 0.00
Total male and female 0 to 15 years D06 Antibiotics.. for dermatological use 2022* 7.62
Total male and female 0 to 15 years D06A Antibiotics for topical use 2022* 7.54
Total male and female 0 to 15 years D06B Chemotherapeutics for topical use 2022* 0.10
Total male and female 0 to 15 years G02B Contraceptives for topical use 2022* 0.00
Total male and female 0 to 15 years H02 Corticosteroids for systemic use 2022* 0.82
Total male and female 0 to 15 years J General antiinfectives for system.use 2022* 14.48
Total male and female 0 to 15 years J01 Antibacterials for systemic use 2022* 14.29
Total male and female 0 to 15 years J02 Antimycotics for systemic use 2022* 0.09
Total male and female 0 to 15 years J02A Antimycotics for systemic use 2022* 0.09
Total male and female 0 to 15 years J04A Drugs for treatment of tuberculosis 2022* 0.01
Total male and female 0 to 15 years J04B Drugs for treatment of lepra 2022* 0.00
Total male and female 0 to 15 years J05 Antivirals for systemic use 2022* 0.06
Total male and female 0 to 15 years M05 Drugs for treatment of bone diseases 2022* 0.00
Total male and female 0 to 15 years M09 Oth.drugs for musculo-skelet.disord. 2022* 0.00
Total male and female 0 to 15 years R03 Drugs for obstruct. airway diseases 2022* 6.56
Total male and female 0 to 15 years R03C Adrenergics for systemic use 2022* 0.00
Total male and female 0 to 15 years R06 Antihistamines for systemic use 2022* 6.36
Total male and female 0 to 15 years R06A Antihistamines for systemic use 2022* 6.36
Total male and female 0 to 15 years V06A Obesity treatment diet formulations 2022* 0.00
Total male and female 0 to 15 years V06C Infant formulas 2022* 0.00
Total male and female 15 to 25 years A02 Drugs for acid related disorders 2022* 1.08
Total male and female 15 to 25 years A02B Drugs for peptic ulcer and gord 2022* 1.08
Total male and female 15 to 25 years A02X Oth. drugs for acid related disord. 2022* 0.00
Total male and female 15 to 25 years A03 Drugs for funct.gastrointest.disord. 2022* 1.49
Total male and female 15 to 25 years A03A Drugs for functional bowel disord. 2022* 0.39
Total male and female 15 to 25 years A14 Anabolic agents for systemic use 2022* 0.00
Total male and female 15 to 25 years B Blood and blood forming organs 2022* 2.37
Total male and female 15 to 25 years D01 Antifungals for dermatological use 2022* 3.73
Total male and female 15 to 25 years D01A Antifungals for topical use 2022* 3.42
Total male and female 15 to 25 years D01B Antifungals for systemic use 2022* 0.40
Total male and female 15 to 25 years D03 Means for wounds & ulcers treatment 2022* 0.00
Total male and female 15 to 25 years D05A Antipsoriatics for topical use 2022* 0.23
Total male and female 15 to 25 years D05B Antipsoriatics for systemic use 2022* 0.00
Total male and female 15 to 25 years D06 Antibiotics.. for dermatological use 2022* 3.42
Total male and female 15 to 25 years D06A Antibiotics for topical use 2022* 2.86
Total male and female 15 to 25 years D06B Chemotherapeutics for topical use 2022* 0.61
Total male and female 15 to 25 years G02B Contraceptives for topical use 2022* 0.72
Total male and female 15 to 25 years H02 Corticosteroids for systemic use 2022* 1.02
Total male and female 15 to 25 years J General antiinfectives for system.use 2022* 15.22
Total male and female 15 to 25 years J01 Antibacterials for systemic use 2022* 13.85
Total male and female 15 to 25 years J02 Antimycotics for systemic use 2022* 0.92
Total male and female 15 to 25 years J02A Antimycotics for systemic use 2022* 0.92
Total male and female 15 to 25 years J04A Drugs for treatment of tuberculosis 2022* 0.02
Total male and female 15 to 25 years J04B Drugs for treatment of lepra 2022* 0.00
Total male and female 15 to 25 years J05 Antivirals for systemic use 2022* 0.38
Total male and female 15 to 25 years M05 Drugs for treatment of bone diseases 2022* 0.01
Total male and female 15 to 25 years M09 Oth.drugs for musculo-skelet.disord. 2022* 0.00
Total male and female 15 to 25 years R03 Drugs for obstruct. airway diseases 2022* 4.65
Total male and female 15 to 25 years R03C Adrenergics for systemic use 2022* 0.00
Total male and female 15 to 25 years R06 Antihistamines for systemic use 2022* 8.10
Total male and female 15 to 25 years R06A Antihistamines for systemic use 2022* 8.10
Total male and female 15 to 25 years V06A Obesity treatment diet formulations 2022* 0.00
Total male and female 15 to 25 years V06C Infant formulas 2022* 0.00
Total male and female 25 to 35 years A02 Drugs for acid related disorders 2022* 2.99
Source: CBS.
Explanation of symbols

Dataset is not available.


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, age and sex.

Data available from: 2006

Status of the figures:
Figures for 2022 are provisional.

Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.

When will new figures be published?
New figures will be published in the last quarter of 2024.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.